Quest Diagnostics (NYSE:DGX) announced that it received FDA emergency use authorization (EUA) for a new laboratory technique for extracting viral RNA. Secaucus, N.J.-based Quest Diagnostics’ new technique is designed to speed up the process of extracting viral RNA from specimens in an effort to expand daily capacity of COVID-19 molecular diagnostic tests in the U.S., according […]
LabCorp COVID-19 test may be used on asymptomatic people
The FDA on Friday added two new indications for the use of a Laboratory Corporation of America (NYSE:LH) COVID-19 RT-PCR diagnostic: to test people who have no symptoms of the virus or have no reason to believe they’ve been exposed; and to allow pooled testing of up to five samples from different people. The test, which received an emergency […]
Quest COVID-19 test wins FDA nod for pooled sampling
The FDA has authorized a Quest Diagnostics (NYSE:DGX) test for COVID-19 to be used with pooled samples — the first such authorization by the agency since Dr. Anthony Fauci, the nation’s leading infectious disease specialist, started publicly discussing pooled-sample testing about three weeks ago. The authorization, announced Saturday, permits the pooled testing of up to four […]
Quest lands FDA nod for at-home COVID-19 test
Quest Diagnostics (NYSE:DGX) has received an FDA emergency use authorization (EUA) for an at-home diagnostic test for COVID-19. The Secaucus, N.J.-based testing giant said the test kit is for individuals to self-collect a nasal specimen at home or in a healthcare setting when determined to be appropriate by a healthcare provider. It allows an individual to […]
Quest Diagnostics launches patient-ordered COVID-19 antibody test
Quest Diagnostics (NYSE:DGX) announced today that consumers can now order a COVID-19 antibody test it launched last week directly from the company, without visiting a doctor’s office. The Secaucus, N.J.-based testing giant said consumers can purchase the antibody test service online for $119 through its QuestDirect business. They will be prompted to schedule an appointment for […]
Quest Diagnostics, Quidel Corp. get emergency nod for COVID-19 tests
The FDA has granted two more companies’ COVID-19 tests emergency use authorizations. Tests by Quest Diagnostics (NYSE:DGX) and Quidel Corp. (NSDW:QDEL) got the nod for distribution within the U.S. without prior clearance or approval. Quest Diagnostics (Secaucus, N.J.) said it will expand testing with its new COVID-19 diagnostic this week from its high-complexity laboratories in Chantilly, Va., […]
Quest Diagnostics posts mixed Q1
Shares in Quest Diagnostics (NYSE:DGX) held steady today after the company met earnings expectations on Wall Street but missed analysts’ sales estimates with its first-quarter results. The Secaucus, N.J.-based company posted profits of $177 million, or $1.27 per share, on sales of $1.88 million for the 3 months ended March 31, for bottom-line growth of 7.9% on sales […]
Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves
Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.
Hill-Rom rises on Q3 prelims, needs new CFO
Rusckowski out, DiSanzo in at Philips Healthcare
Steve Rusckowski is leaving the corner office at Philips Healthcare (NYSE:PHG) to succeed Quest Diagnostics (NYSE:DGX) CEO Surya Mohapatra.
Conceptus names new CEO, lowers 2012 guidance | Personnel Moves
In a sudden switch, Conceptus (NSDQ:CPTS) named Keith Grossman president & CEO upon the resignation of Mark Sieczkarek, whose departure was announced on the heels of lowered sales guidance for 2012.
Sieczkarek’s resignation, after 7 years at the helm, was announced simultaneously with Grossman’s appointment. Grossman will join the company’s board of directors, from which Sieczkarek also resigned.
